TEACHABLE MEDICAL NEWS

CREATED BY ELEASYS LLC

Tag: red bone marrow

Can we chase down and kill the hiding cancer cells in our bodies?

By

On August 25, 2025

In lymphatic and immune system

Teachable moment in classrooms:

  1. cellular basis of life chapter – DNA specifies protein structure
  2. blood chapter – role of red bone marrow in hemopoesis
  3. immune system chapter – development of T and B cells and their role in the immune response
  4. immune system chapter – structure of antibodies and their binding to specific target molecules

The news item:  Recently the following news item appeared online:

Talvey Giving Patients With Heavily Pretreated Multiple Myeloma ‘a New Lease on Life’

The recent FDA approval of Talvey for heavily pretreated multiple myeloma results in an improved response to therapy and a manageable side effect profile.

The report describes that the Talvey treatment is given to multiple myeloma patients whose cancer returned despite several previous treatment with conventional drugs. The report also describes the several side effects of Talvey treatment.

So, Why Do I Care??  Every year multiple myeloma kills over 12,000 people in the USA alone. This type of cancer frequently reappears after conventional cancer treatments, and any new treatment that extends patient life after previous treatments are exhausted, is important to research.

Plain English, Please!!! First, let’s talk about what multiple myeloma is. This disorder represents a cancerous, uncontrolled cell division of plasma cells in the red bone marrow. A plasma cell is a type of white blood cell that produces antibodies during immune response. When the cancerous plasma cells quickly multiply and overtake the red bone marrow, fewer red blood cells and platelets are made, leading to fatigue, tiredness and easy bleeding.

Second, let’s talk about how Talvey works. If we want the immune system to kill cancer cells it would make sense to bring the immune system’s cells right to the cancer cells. Metaphorically speaking, picture

Read More

How can the genetic engineering treatment of red bone marrow by Zynteglo help beta-thalassemia patients?

By

On August 5, 2023

In cardiovascular system, cellular basis of life

Teachable moment in classrooms:

  1. cellular basis of life chapter – concept of one gene, one protein
  2. cellular basis of life chapter – concept of gene mutation leading to protein malfunction
  3. cellular basis of life chapter – mRNA translation is needed for protein synthesis
  4. blood chapter – red blood cells are made in the red bone marrow
  5. blood chapter – the role of globin chains in hemoglobin function

The news item:  Recently the following report appeared:

https://timesnewscity.com/bluebirds-2-8m-gene-therapy-becomes-most-expensive-drug-after-us-approval/

The article states that about 1,500 patients need blood transfusion every 2-5 weeks, and that Zynteglo is a gene therapy.

So, Why Do I Care??

The most severe type of beta-thalassemia causes serious anemia with the symptoms of continuous lethargy, fatigue, tiredness. To fight this, the patients require regular blood transfusions. Those patients expected to live until about the age of 50. in the US there are about 1500-3000 such patients. New treatment approaches give the hope of longer life to those patients.

Plain English, Please!!! First, let’s talk about what beta-thalassemia is. This disorder is caused by the missing beta-globin protein in hemoglobin. The protein is missing because the beta-globin gene has mutations that prevent the mRNA formation for beta-globin. The outcome is that hemoglobin is abnormal, because it is formed only from the alpha-globin proteins. Such abnormal hemoglobin makes cells of the red bone marrow to burst, reducing the production of oxygen transporter red blood cells. The decreased oxygen transport cause anemia, the starvation of cells for oxygen.

Second, let’s talk about how red blood cells are made. The damage of the beta-thalassemia is done in the red bone marrow, where red blood cells are formed. In the red bone marrow the red blood cells move

Read More

Why does a bone marrow transplant create news in the National Hockey League?

By

On January 1, 2020

In cardiovascular system, cellular basis of life, lymphatic and immune system

TeachableMedicalNews article 12312019

Teachable moment in classrooms:

  1. cellular basis of life chapter – formation of cancer cells
  2. blood chapter – stem cells in the formation of white blood cells in red bone marrow
  3. blood chapter – stem cells in red bone marrow can be moved from one person to another
  4. immune system chapter – role of macrophages and cytokines in starting immune reactions

The news item:  A happy introduction was in the news recently where a bone marrow donor and the bone marrow recipient met in person the first time:

Eruption of joy as Laila Anderson meets her bone marrow donor

TOWN AND COUNTRY, Mo. – An 11-year-old came face-to-face with the man whose bone marrow donation gave her a second chance at life. There were hundreds of people gathered at the Be the Match gala in Town and Country to witness the special moment and to support young Laila Anderson’s unique journey.

The article mentions that Laila Anderson’s life was saved by the bone marrow donation. 

Read More

Can you strengthen the immune system of cancer patients in chemotherapy treatment?

By

On December 21, 2019

In cardiovascular system, cellular basis of life, lymphatic and immune system

TeachableMedicalNews article 12202019

Teachable moment in classrooms:

  1. cellular basis of life chapter – formation of cancer cells
  2. cellular basis of life chapter – DNA and mitosis
  3. blood chapter – formation of white blood cells in red bone marrow
  4. immune system chapter – immune protection by white blood cells 

The news item:  The pharmaceutical Neulasta was in the news recently:

Mylan CEO promises Neulasta biosimilar will offer “significant savings” for patients

It’s been nearly two years since the pharmaceutical giant took tremendous heat for the rising cost of EpiPens

The article mentions that a new company will be making a similar and cheaper drug to Neulasta, and that Neulasta is used to reduce infections in patients during cancer treatment.

So, Why Do I Care??  Cancer patients are frequently treated with drugs to kills the cancer cells. Such chemotherapy drugs are used to treat most of the 1.7 million new cancer cases each year in the USA.  Chemotherapy treatments have many damaging side effects on the patients.  Minimizing of those side effects improves patient comfort, survival, and the success of the chemotherapy treatment.

Plain English, Please!!! First, let’s; talk about chemotherapy.  Cancers grow by cells dividing faster than normal cells of the body, and the chemotherapy drugs are used to stop or slow the division of cancer cells.  One side effect of chemotherapy treatment is that normal cells are also stopped from dividing. One of those normally quickly dividing group of cells is located in the red bone marrow.

Second, let’s talk about red bone marrow.  This red, toothpaste-like mush of cells is trapped inside our spongy bones, like breastbone, pelvic bone, and others.  Millions of new red and white blood cells are created by cell division in the red bone marrow every day.  Picture cell division as a car driving at normal speed; you have to keep your foot on the gas pedal.  Chemotherapy drugs are like a foot on the brake pedal; as they slow down cell division, they slow down red and white blood cell production in the bone marrow.

Third, let’s talk about white blood cells.  The white blood cells defend our bodies against bacteria, viruses and fungi. Every day we lose thousands of white blood cells during that defense, so we need constant replacement.  When the cell division in the red bone marrow is slowed by chemotherapy drugs, the replacement of white blood cells slows down, and bacteria and virus infections can get a foothold in the body.  Neulasta (and similar drugs) speeds up white blood cell creation; they step on the gas pedal of cell division in the bone marrow even during chemotherapy treatment.  That provides enough white blood cells to defend the body better against invaders during chemotherapy treatment.

 

Powered by WordPress & Theme by Anders Norén